Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-212-0 | CAS number: 68201-32-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2008-01-14 to 2008-02-29
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- purity of the test substance was not provided
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- Purity of the test substance was not provided.
- Principles of method if other than guideline:
- N/A
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Certificate from "The Department of Health of the Government of the United Kingdom"
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Asphalt, sulfonated, sodium salt
- EC Number:
- 269-212-0
- EC Name:
- Asphalt, sulfonated, sodium salt
- Cas Number:
- 68201-32-1
- Molecular formula:
- UVCB
- IUPAC Name:
- Asphalt, sulfonated, sodium salt
- Details on test material:
- - Name of test material (as cited in study report): Sodium sulfonated asphalt
- Molecular formula (if other than submission substance): N/A
- Molecular weight (if other than submission substance): N/A
- Smiles notation (if other than submission substance): N/A
- InChl (if other than submission substance): N/A
- Structural formula attached as image file (if other than submission substance): N/A
- Substance type: active
- Physical state: black solid
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/Ca (CBA/CaOlaHsd)
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan UK Limited, Bicester, Oxon, UK
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 12-23 g
- Housing: Animals were individually housed in suspended solid-floor polypropylene cages furnished with softwood woodflakes.
- Diet (e.g. ad libitum): ad libitum (Certified Rat and Mouse Diet)
- Water (e.g. ad libitum): ad libitum (tap)
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (deg. C): The temperature was controlled to remain within a target range of 19-25 deg C. Any occasional deviation from this target was considered not to have affected the purpose or integrity of the study.
- Humidity (%): The relative humidity was controlled to remain within a target range of 30-70 %. Any occasional deviation from this target was considered not to have affected the purpose or integrity of the study.
- Air changes (per hr): ~15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: N/A To: N/A
Study design: in vivo (LLNA)
- Vehicle:
- dimethyl sulphoxide
- Concentration:
- 2.5%, 5%, or 10% w/w in DMSO
- No. of animals per dose:
- - FIve animals
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: DMSO was chosen as the most suitable vehicle for the test substance.
- Irritation: N/A
- Lymph node proliferation response: N/A
-Other: One mouse was treated by daily application of 25 uL of the test substance as a suspension at a concentration of 10 % w/w in DMSO, to the dorsal surface of each ear for 3 consecutive days (Days 1, 2, 3). This was found to be the highest concentration suitable for dosing in the most suitable vehicle. The mouse was observed twice daily on Days 1, 2 and 3 and once daily on Days 4, 5 and 6. Any signs of toxicity or excessive local irritation noted during this period were recorded. The bodyweight was recorded on Day 1 (prior to dosing) and on Day 6.
No signs of systemic toxicity were noted.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: 3HTdR Incorporation
- Criteria used to consider a positive response: The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph nodes from each individual animal and as the ratio of 3HTdR incorporation into lymph node cells of test nodes relative to that recorded for the control nodes (Stimulation Index). The test substance or positive control substance was regarded as a sensitizer if at least one concentration of the test substance or positive control substance resulted in a threefold or greater increase in 3HTdR incorporation compared to control values. Any test substance failing to produce a threefold or greater increase in 2HTdR incorporation was classified as a "non-sensitizer".
TREATMENT PREPARATION AND ADMINISTRATION:
The test substance was freshly prepared in DMSO. The mice were treated by daily application of 25 uL of the appropriate concentration to the dorsal surface of each ear for three consecutive days (Days 1, 2 and 3). The test substance formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette. Five days following the first topical application of the test substance (day 6) all mice were injected via the tail vein with 250 uL of phosphate buffered saline (PBS) containing [3H]-methyl-thymidine giving a total of 20 uCi to each mouse.
Five hours following the administration of 3HTdR all mice were killed by carbon dioxide asphyxiation. The draining auricular lymph nodes were excised and processed. 1 mL of PBS was added to the lymph nodes.
A single cell suspension of the lymph node cells for each individual animal was prepared by gentle mechanical disaggregation through a 200-mesh stainless steel gauze. The lymph node cells were rinsed through the gauze with 4 mL of PBS into a petri dish. The lymph node suspension was transferred to a centrifuge tube. The petri dish was washed with an additional 5 mL PBS and added to the centrifuge tube. The lymph node cells were pelleted at 1400 rpm for 10 min. Pellet was resuspended in 10 mL PBS and re-pelleted. To precipitate out the radioactive material, the pellet was resuspended in 3 mL of 5 % Trichloroacetic acid (TCA).
After ~ 18 h incubation at ~ 4 degrees C, the precipitates were recovered by centrifugation at 2100 rpm for 10 min, resuspended in 1 mL of TCA and transferred to 10 mL of scintillation fluid. 3HTdR incorporation was measured by B-scintillation counting. The "PolyQ" vials counting the samples and scintillation fluid were placed in the sample changer of the scintillator and left for ~ 20 min. After ~ 20 min., the vials were shaken vigorously. The number of radioactive disintegrations per minute was then measured using the Beckman LS6500 scintillation system.
- Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Data were processed to give group mean values for disintegrations per minute and standard deviations where appropriate. Individual and group mean disintegrations per minute values were assessed for dose response relationships by analysis of homogeneity of variance followed by one way analysis of variance (ANOVA). In the event of a significant result from the ANOVA, pairwise comparisons were performed between control and treated groups. For homogeneous datasets, Dunnett's Multiple Comparison test was used and for non-homogeneous datasets, Dunnett's T3 Multiple Comparison Method was used.
Results and discussion
- Positive control results:
- A stimulation index of greater than 3 was recorded for the positive control at a concentration of 15 % v/v in DMSO. The mean dpm/animal was 4877.88 (p < 0.01) for the positive control.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: - A stimulation index of < 3 was recorded for the three concentrations of the test substance (2.5%, 5%, 10% w/w in DMSO).
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: - The mean dpm/animal was 1554.00, 1773.71, 1760.30, 2339.69 for the 0, 2.5%, 5%, and 10% w/w in DMSO test groups, respectively.
- Parameter:
- SI
- Value:
- 1.14
- Test group / Remarks:
- 2.5% w/w in DMSO in 5 animals
- Remarks on result:
- other: Negative
- Parameter:
- SI
- Value:
- 1.13
- Test group / Remarks:
- 5% w/w in DMSO in 5 animals
- Remarks on result:
- other: Negative
- Parameter:
- SI
- Value:
- 1.51
- Test group / Remarks:
- 10% w/w DMSO in 5 animals
- Remarks on result:
- other: Negative
- Parameter:
- SI
- Value:
- 3.14
- Test group / Remarks:
- Positive control substance, 15% v/v in DMSO in 5 animals
- Remarks on result:
- other: positive
Any other information on results incl. tables
Individual Disintegrations per Minute and Stimulation Indices |
|||||
Treatment Group |
Animal Number |
dpm / Animala |
Mean dpm / animal (SD) |
Stimulation Indexb |
Result |
Vehicle DMSO |
1-1 |
1113.55 |
1554.00 (± 616.29) |
N/A |
N/A |
1-2 |
1508.32 |
||||
1-3 |
2243.28 |
||||
1-4 |
2095.62 |
||||
1-5 |
809.21 |
||||
Test Substance 2.5% w/w in DMSO |
2-1 |
1962.85 |
1773.71 (± 489.31) |
1.14 |
Negative |
2-2 |
1090.28 |
||||
2-3 |
2316.77 |
||||
2-4 |
1467.58 |
||||
2-5 |
2031.06 |
||||
Test Substance 5% w/w in DMSO |
3-1 |
1259.81 |
1760.30 (± 618.19) |
1.13 |
Negative |
3-2 |
1528.48 |
||||
3-3 |
1192.76 |
||||
3-4 |
2235.44 |
||||
3-5 |
2585.00 |
||||
Test Substance 10% w/w in DMSO |
4-1 |
1299.64 |
2339.69 (± 834.69) |
1.51 |
Negative |
4-2 |
3593.71 |
||||
4-3 |
2540.71 |
||||
4-4 |
2187.25 |
||||
4-5 |
2077.15 |
||||
Positive Control Substance 15% v/v in DMSO |
5-1 |
8695.73 |
4877.88** (± 2159.72) |
3.14 |
Positive |
5-2 |
3601.66 |
||||
5-3 |
4180.21 |
||||
5-4 |
3591.15 |
||||
5-5 |
4320.65 |
||||
aTotal number of lymph nodes per animal is 2. |
|||||
bStimulation Index of 3.0 or greater indicates a positive result. |
|||||
**Statistically different from the control group p < 0.01. |
CLINICAL OBSERVATIONS AND MORTALITY DATA:
- There were no deaths
- No signs of systemic toxicity were noted in the test animals, the vehicle control animals or the positive control animals
BODYWEIGHT:
- One animal in the 10% group presented an insignificant weight loss with no systemic adverse effects.
- Overall bodyweight changes between days 1 and 6 were comparable to those observed in the vehicle control group over the same period.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance was considered to be a non-sensitizer under the conditions of the test.
- Executive summary:
N/A
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.